European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

CD4 T AND B LYMPHOCYTES IN HEPATITIS B PATIENTS: ROLE IN ACUTE AND CHRONIC INFECTION

Cel

"Hepatitis B virus (HBV), an hepatotropic non-cytopathic DNA virus, still represents a global health problem, with million of deaths for year because of complication of chronic infection. Chronic infection and its outcome are believed a consequence of defective antiviral response, mainly in T-cell arm, probably mediated by prolonged exposition to large amounts of viral antigens. Recently, many advancements have been done on virus-specific CD8 dysfunction or “exhaustion”, while far less is known about the role of other components of immune response. Thus, aims of the present proposal are the evaluation of phenotype and function of CD4 T cells and B cells in both acute self-limited HBV infection, and in chronic HBV, in order to identify correlates of protection, and additional markers of immune impairment. The project will focus on multiple immunological parameters: dynamics of CD4 memory development, and lineage differentiation, B cells memory development and antibodies functional assays, in acute self limited infection; degree and role, if any, of CD4 T and B cells exhaustion in chronic infection, with different degree of viral control. The analysis will be conducted on cryopreserved PBMCs samples of patients affected by HBV (acute or chronic) and will be performed by both molecular and cellular approaches. Interestingly, many of them have been developed at the host institution. Thus, in addition to the possibility to develop a challenging project of strong impact, due to training that the host will provide, the permanence at the host institution, where multiple competences of very high scientific level coexist, will represent for the applicant an unique experience for scientific and working career."

Zaproszenie do składania wniosków

FP7-PEOPLE-2011-IEF
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA
Wkład UE
€ 248 451,40
Adres
VIA FRANCESCO CHIESA 5
6500 Bellinzona
Szwajcaria

Zobacz na mapie

Region
Schweiz/Suisse/Svizzera Ticino Ticino
Rodzaj działalności
Research Organisations
Kontakt administracyjny
Antonio Lanzavecchia (Prof.)
Linki
Koszt całkowity
Brak danych